All pages in one view


First patient included in the CRUZ-SENIOR STUDY.
CAN-SHOCK starts into the next phase!
Another important milestone has been achieved, allowing the Institute for Myocardial Infarction Research to generate new data to understand the efficacy and safety of cangrelor in high-risk patients.
Interim Results COVID-19-Register RLP
Day-to-day research results on the COVID-19 situation in hospitals, based on our own COVID-19 registry.  
Renewed interim analysis of the COVID-19 registry provides important information on the situation in hospitals.
Presentation of the second evaluation of the COVID-19 registry for Rhineland-Palatinate by Dr. Anselm K. Gitt, board of directors of Foundation Institute for Myocardial Infarction Research in and study director of the COVID-19 registry...
CAN-SHOCK gets off to a start
The ethics committee approved the observational monitoring design for the CAN-SHOCK registry with no further conditions.

We would like to get to know you and your ideas.

Start project

Consent to the use of cookies

In order to make our website more appealing to visitors and to enable the use of certain functions, we use cookies on various pages. By continuing to use the website, you consent to the use of cookies. Find out more.

I agree
Scroll to top